Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol

BACKGROUND: Recent studies demonstrated the efficacy of S-1-based adjuvant chemotherapy administered for six months after curative surgery for stage III gastric cancer; however, it is unproven whether this type of combination chemotherapy is more effective than the standard adjuvant chemotherapy of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Namikawa, Tsutomu, Maeda, Hiromichi, Kitagawa, Hiroyuki, Oba, Koji, Tsuji, Akihito, Yoshikawa, Takaki, Kobayashi, Michiya, Hanazaki, Kazuhiro
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812232/
https://ncbi.nlm.nih.gov/pubmed/29439671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4109-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars